ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS
    3.
    发明申请
    ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS 审中-公开
    ISOXAZOLINE组合物及其作为抗菌剂的用途

    公开(公告)号:WO2009024541A3

    公开(公告)日:2010-04-01

    申请号:PCT/EP2008060732

    申请日:2008-08-15

    Abstract: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl- isoxazo lin-3 -yl)-benzamides) and 4-(isoxazolinyl)- benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.

    Abstract translation: 本发明涉及用于控制动物及其环境的寄生虫感染的方法,更具体地说,涉及使用异恶唑啉来控制动物或其环境中或动物或其环境中的寄生虫以及治疗动物寄生虫的方法。 异恶唑啉包括4-(异恶唑啉基) - 苯甲酰胺(具体地,取代的4-(5-(卤代甲基)-5-苯基 - 异恶唑啉-3-基) - 苯甲酰胺)和4-(异恶唑啉基) - 苯并硫代酰胺(具体地,取代的4 - (5-(卤代甲基)-5-苯基异恶唑啉-3-基)-benzothioamides)。 本发明还涉及包含用于此类方法的异恶唑烷的组合物,异恶唑啉用于制备用于此类方法的药物的用途,以及包含用于进行此类方法的异恶唑烷的试剂盒。 本发明还涉及异恶唑啉作为药物的用途,特别是可以在上述方法中使用的药物。

    DITHIOCARBAZATE DERIVATIVES AND THEIR USE AS PESTICIDES
    7.
    发明申请
    DITHIOCARBAZATE DERIVATIVES AND THEIR USE AS PESTICIDES 审中-公开
    二盐酸衍生物及其作为杀虫剂的用途

    公开(公告)号:WO99023066A1

    公开(公告)日:1999-05-14

    申请号:PCT/GB1998/003197

    申请日:1998-10-27

    CPC classification number: A01N47/42 C07C337/04 C07C2602/08 C07D317/56

    Abstract: A compound of formula (I) wherein X is O or NH; Y is CH or N; W is methyl or methoxy; R and R , which may be the same or different, are alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl each of which may be substituted; R and R , which may be the same or different, have the same meaning as R , R and R together with the atoms to which they are attached form an optionally substituted 5- to 7-membered heterocyclyl group; R is optionally substituted alkyl; R is alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, halogen, cyano, nitro, alkoxy, alkylthio, haloalkoxy or optionally substituted phenyl; and q is 0 to 4, wherein when q is 2, 3 or 4, each R may be the same or different.

    Abstract translation: 式(I)的化合物,其中X是O或NH; Y是CH或N; W是甲基或甲氧基; R 1和R 6可以相同或不同,为可以被取代的烷基,烯基,炔基,碳环基或杂环基; R 2和R 3可以相同或不同,具有与R 1,R 2和R 3一起与它们所连接的原子一起形成任选取代的相同含义 5-至7-元杂环基; R 4是任选取代的烷基; R 5是烷基,卤代烷基,烯基,炔基,环烷基,卤素,氰基,硝基,烷氧基,烷硫基,卤代烷氧基或任选取代的苯基; 且q为0至4,其中当q为2,3或4时,每个R 5可以相同或不同。

    TRIS-SUBSTITUTED BIGUANIDE COMPOUNDS AND THEIR USES

    公开(公告)号:WO2020097536A1

    公开(公告)日:2020-05-14

    申请号:PCT/US2019/060577

    申请日:2019-11-08

    Abstract: Novel tris-substituted biguanide compounds are made by reaction of sodium dicyanamide with a trifunctional primary amine followed by reaction with anilines. The tris-substituted biguanide compounds are potent biocide and useful as a disinfectant. The novel compounds have biocidal activity comparable to those of widely used chlorhexidine with respect to width of antibacterial spectrum and in immediate effectiveness. The novel tris-substituted biguanide compounds can also be used for cleaning wounds, preventing dental plaque, treating yeast infections of the mouth, and to keep urinary catheters from blocking, These novel compounds have superior aqueous solubility and bioavailability and have potent antibacterial activity especially against A. baumanni and K. pneumonia.

Patent Agency Ranking